Biological Weapons --
Ebola
|
As a biological warfare agent, the primary threat is delivery
by aerosol release.
|
. |
Symptoms

|
After an incubation period of 2 - 21 days, Ebola is often characterized
by the sudden onset of high fever, weakness, diarrhea, muscle pain, headache and sore throat. These symptoms
are usually seen within a few days of becoming infected. Within
a week, patients experience chest pain, shock and death.
Some people also have vomiting, hiccups, rash, red and itchy eyes,
bloody diarrhea, blindness and internal and external bleeding.
|
How does it spread? |
Ebola is transmitted by direct contact with the blood, secretions,
organs or semen of infected persons so special caution must be
used in handling sharps, needles, etc. Transmission through semen
may occur up to 7 weeks after clinical recovery, as with Marburg
hemorrhagic fever. Health care workers have frequently been infected
while attending patients.
It's host is still unknown
|
Diagnosis

|
Specialized laboratory tests on blood specimens (which are not
commercially available) detect specific antigens or antibodies
and/or isolate the virus. These tests present an extreme biohazard
and are only conducted under maximum containment conditions.
(Sewage, bulk blood, suctioned fluids, secretions, and excretions
should be autoclaved, processed in a chemical toilet, or treated
with a 5% chlorine solution for at least 5 minutes in bedpan or
commode prior to flushing.)
|
Treatment

|
No specific treatment exists for Ebola hemorrhagic fever, other
than supportive therapy.
|
Vaccine
|
None available
|
Mortality
|
Mortality is substantial, ranging from 50% - 90%. There should
be minimal handling of the body, with sealing of the corpse in
leak-proof material for prompt burial or cremation.
Survivors may be left with long-term challenges such as blindness,
hearing loss, and other neuralgic and eye problems.
|
Sources:
CDC; http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/ebola.htm
USAMRIID's Medical Management of Biological Casualties Handbood;
Fourth Edition February 2001; pages 9-10; http://usamriid.detrick.army.mil/education/bluebook/bluebook.pdf
Federation of American Scientists; http://www.fas.org/nuke/intro/bw/agent.htm
Virtual Naval Hospital: Treatment of Biological Warfare Agent
Casualties; http://www.vnh.org/FM8284/index.html
|
|
All contents © 2001 Stan and Holly Deyo. All rights reserved.
This information may be used by you freely for noncommercial use
only with
my name and E-mail address attached.
Holly Deyo, E-mail: hollydeyo@standeyo.com
URL: https://standeyo.com/News_Files/NBC/Bio.Bugs.Plague.html